CORDIS Project
Funding breakdown and partner intelligence are Premium
Sign in and upgrade to Premium for EU contribution totals, consortium analytics, OpenAlex research context, and AI summaries. · 0 consortium intelligence fields visible of 1
Start free • Cancel anytime • 14-day refund guarantee
GLIOMARK focuses on validating the blood-brain barrier's permeability as a biomarker for glioma diagnosis using a radiotracer and imaging technology. The project aims to develop a diagnostic kit, GlioTect, to enable non-invasive glioma grading and diagnosis, improving patient management.
Objective of GLIOMARK is to clinically validate the permeability of the blood brain barrier (BBB) as an in vivo biomarker for the diagnosis and grading of gliomas.
This will be accomplished by means of the radiotracer 99mTc-tetrofosmin (TTF) and the imaging technique Single-Photon Emission Computer To-mography (SPECT).
The outcome of GLIOMARK is GlioTect, a diagnostic kit containing handling/diagnostic instructions and tetrofosmin.
The latter has to be reconstituted with 99mTc pertechnetate to y…
CONSULTECH TECHNOLOGIEBERATUNG GMBH
Partner organizations (coordinator is shown above), with normalized type and CORDIS activity type. Guests see up to 4 partners.
PROACTINA SA CHEMICAL SOLUTIONS PRO ACTINA AE
Greece, MAROUSI ATHENS
Type: SME
Activity type: Private for-profit entities (excluding Higher or Secondary Education Establishments)
SME: Yes
Similar projects, consortium collaboration history, frequent partners, and OpenAlex research context.
Guests see up to 5 EuroSciVoc fields.
Guests see up to 5 topics.
